Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferation

Publication date: 1 June 2021Source: Cell Reports, Volume 35, Issue 9Author(s): Pavan Kumar Puvvula, Yao Yu, Kaelan Renaldo Sullivan, Henok Eyob, Julian Rosenberg, Alana Welm, Chad Huff, Anne M. Moon
Source: Cell Reports - Category: Cytology Source Type: research